In this study, IHC staining with the four antibodies, and tumor “activity,” did not correlate with β-catenin mutation, and there was no clear difference in CTNNB1 mutation between Sets A and B of the earlier gene expression study, although a larger study might identify a correlation. This evidence concerns the gene CTNNB1 and neoplasm.